Dong Shao

Dong (Helen) Shao, PharmD, RPh, currently serves as the Director of Market Access and Channel Strategy for Nemolizumab at Galderma since April 2023. Prior experience includes roles at Takeda as Global Access Lead and Senior Manager in Managed Markets Planning & Analytics, where significant contributions involved enhancing access strategies for various products and establishing forecasting models. Additional roles at Shire and Market Access Solutions LLC included developing payer contracting playbooks and managing analytics projects for pharmaceuticals. Earlier experience encompasses positions at Dymaxium Inc., Walmart, and multiple internships, culminating in a Doctor of Pharmacy and Bachelor of Science in Pharmaceutical Sciences from Purdue University, alongside a Comparative Effectiveness Research Certificate from the Academy of Managed Care Pharmacy.